JNO Literature Commentary

J Neuroophthalmol. 2021 Jun 1;41(2):272-277. doi: 10.1097/WNO.0000000000001267.

Abstract

June 2021' In this issue of JNO, Drs. M. Tariq Bhatti and Mark L. Moster discuss the following 6 articles: Vynckier J, Demeestere J, Lambert J. Black-blood MRI in Giant Cell Arteritis. J Rheumatol. 2021;48:301-302.Hwang CJ, Nichols EE, Chon BH, Perry JD. Bilateral dysthyroid compressive optic neuropathy responsive to teprotumumab. Eur J Ophthalmol. 2021:1120672121991042. doi: 10.1177/1120672121991042. Epub ahead of print. PMID: 33525898.Narayanaswami P, Sanders DB, Wolfe G, Benatar M, Cea G, Evoli A, Gilhus NE, Illa I, Kuntz NL, Massey J, Melms A, Murai H, Nicolle M, Palace J, Richman D, Verschuuren J. International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update. Neurology. 2021;96:114-122.Mastrangelo V, Merli E, Rucker JC, Eggenberger ER, Zee DS, Cortelli P. Neuro-Ophthalmological Findings in Early Fatal Familial Insomnia. Ann Neurol. 2021. doi: 10.1002/ana.26008. Epub ahead of print. PMID: 33386648.D'Antona L, Jaime Merchan MA, Vassiliou A, et al. Clinical Presentation, Investigation Findings, and Treatment Outcomes of Spontaneous Intracranial Hypotension Syndrome: A Systematic Review and Meta-analysis. JAMA Neurol. Published online January 04, 2021. doi:10.1001/jamaneurol.2020.4799.Simonett JM, Skalet AH, Lujan BJ, Neuwelt EA, Ambady P, Lin P. Risk Factors and Disease Course for Blood-Brain Barrier Disruption-Associated Maculopathy. JAMA Ophthalmol. 2021;139:143-149. doi: 10.1001/jamaophthalmol.2020.5329. PMID: 33270081; PMCID: PMC7716256.

Publication types

  • Comment

MeSH terms

  • Giant Cell Arteritis*
  • Humans
  • Neurology*
  • Optic Nerve
  • Optic Nerve Diseases*
  • Risk Factors